HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
DC 015
a selective alpha1-adrenoceptor antagonist; structure given in first source
Also Known As:
3-((4-(2-methoxyphenyl)piperazin-1-yl)methyl)-2,3-dihydroimidazo(1,2-c)quinazolin-5(6H)-one; DC-015; DL-028
Networked:
2
relevant articles (
0
outcomes,
1
trials/studies)
Bio-Agent Context: Research Results
Heterocyclic Compounds: 198
Fused-Ring Heterocyclic Compounds
2-Ring Heterocyclic Compounds
Quinazolines: 402
DC 015: 2
Related Diseases
1.
Portal Hypertension
12/01/1998 - "
The present study was undertaken to investigate the hemodynamic effects of chronic DL-028 administration, alone or in combination with octreotide, in rats with portal hypertension.
"
12/01/1998 - "
Hemodynamic effects of 8-day DL-028 and octreotide administration in rats with portal hypertension.
"
12/01/1998 - "
Although either DL-028 or octreotide ameliorated portal hypertension and splanchnic hyperemia in portal-hypertensive rats, octreotide treatment exerted more beneficial hemodynamic effects than DL-028 treatment.
"
2.
Hypertension (High Blood Pressure)
04/01/1996 - "
Concurrently, DC-015 may thus hold some advantage for the reduction of two of the major risk factors, hypertension and hyperlipidemia, for cardiovascular diseases.
"
3.
Hyperlipidemias (Hyperlipidemia)
04/01/1996 - "
Concurrently, DC-015 may thus hold some advantage for the reduction of two of the major risk factors, hypertension and hyperlipidemia, for cardiovascular diseases.
"
4.
Hyperemia
12/01/1998 - "
Although either DL-028 or octreotide ameliorated portal hypertension and splanchnic hyperemia in portal-hypertensive rats, octreotide treatment exerted more beneficial hemodynamic effects than DL-028 treatment.
"
5.
Cardiovascular Diseases (Cardiovascular Disease)
04/01/1996 - "
Concurrently, DC-015 may thus hold some advantage for the reduction of two of the major risk factors, hypertension and hyperlipidemia, for cardiovascular diseases.
"
Related Drugs and Biologics
1.
Octreotide (Sandostatin)